HK1119163A1 - Tetracyclic compounds, a process for their preparation and pharmaceutical compositions containing them - Google Patents

Tetracyclic compounds, a process for their preparation and pharmaceutical compositions containing them

Info

Publication number
HK1119163A1
HK1119163A1 HK08110616.5A HK08110616A HK1119163A1 HK 1119163 A1 HK1119163 A1 HK 1119163A1 HK 08110616 A HK08110616 A HK 08110616A HK 1119163 A1 HK1119163 A1 HK 1119163A1
Authority
HK
Hong Kong
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
tetracyclic compounds
tetracyclic
Prior art date
Application number
HK08110616.5A
Other languages
English (en)
Inventor
Jean-Louis Peglion
Christophe Poitevin
Mark Millan
Mauricette Brocco
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of HK1119163A1 publication Critical patent/HK1119163A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HK08110616.5A 2006-09-26 2008-09-24 Tetracyclic compounds, a process for their preparation and pharmaceutical compositions containing them HK1119163A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0608413A FR2906249B1 (fr) 2006-09-26 2006-09-26 Composes tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
HK1119163A1 true HK1119163A1 (en) 2009-02-27

Family

ID=37877016

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08110616.5A HK1119163A1 (en) 2006-09-26 2008-09-24 Tetracyclic compounds, a process for their preparation and pharmaceutical compositions containing them

Country Status (32)

Country Link
US (1) US7470683B2 (pl)
EP (1) EP1905775B1 (pl)
JP (1) JP2008100995A (pl)
KR (1) KR100934315B1 (pl)
CN (1) CN101153043B (pl)
AR (1) AR062950A1 (pl)
AT (1) ATE480544T1 (pl)
AU (1) AU2007219281A1 (pl)
BR (1) BRPI0703655A2 (pl)
CA (1) CA2603274C (pl)
CY (1) CY1110799T1 (pl)
DE (1) DE602007009004D1 (pl)
DK (1) DK1905775T3 (pl)
EA (1) EA013406B1 (pl)
ES (1) ES2351945T3 (pl)
FR (1) FR2906249B1 (pl)
GE (1) GEP20104877B (pl)
HK (1) HK1119163A1 (pl)
HR (1) HRP20100605T1 (pl)
MA (1) MA29371B1 (pl)
MX (1) MX2007011524A (pl)
MY (1) MY142517A (pl)
NO (1) NO20074889L (pl)
NZ (1) NZ561905A (pl)
PL (1) PL1905775T3 (pl)
PT (1) PT1905775E (pl)
RS (1) RS51418B (pl)
SG (1) SG141382A1 (pl)
SI (1) SI1905775T1 (pl)
UA (1) UA96125C2 (pl)
WO (1) WO2008037888A2 (pl)
ZA (1) ZA200708215B (pl)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420480A (en) * 1981-11-20 1983-12-13 Merck & Co., Inc. Hexahydronaphth[1,2-b]-1,4-oxazines
CA1204745A (en) * 1981-11-20 1986-05-20 Merck Co. Hexahydronaphth (1,2-b) -1,4 -oxazines
FR2721027B1 (fr) 1994-06-08 1996-07-19 Adir Nouveaux dérivés tétracycliques de la 1,4-oxazine, leur procédé de préparation et les compositions pharmaceutiques les contenant.
FR2741074B1 (fr) * 1995-11-09 1997-12-19 Adir Nouveaux composes tetracycliques de la 1,4-oxazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2767825A1 (fr) * 1997-09-01 1999-02-26 Adir Nouvelles trans-3,4,4a,5,6,10b-hexahydro-2h-napht°1,2-b!-1, 4-oxazines disubstituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2845994B1 (fr) * 2002-10-18 2006-05-19 Servier Lab Nouveaux derives de benzo[e][1,4]oxazino[3,2-g]isoindole substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
KR100934315B1 (ko) 2009-12-29
EA200701807A1 (ru) 2008-04-28
EP1905775A1 (fr) 2008-04-02
MX2007011524A (es) 2009-02-16
MY142517A (en) 2010-12-15
CN101153043B (zh) 2011-01-19
US7470683B2 (en) 2008-12-30
PT1905775E (pt) 2010-11-17
CY1110799T1 (el) 2015-06-10
DK1905775T3 (da) 2010-12-06
EP1905775B1 (fr) 2010-09-08
CN101153043A (zh) 2008-04-02
SI1905775T1 (sl) 2010-10-29
AU2007219281A1 (en) 2008-04-10
FR2906249A1 (fr) 2008-03-28
SG141382A1 (en) 2008-04-28
RS51418B (en) 2011-02-28
BRPI0703655A2 (pt) 2009-05-19
US20080076765A1 (en) 2008-03-27
PL1905775T3 (pl) 2011-03-31
JP2008100995A (ja) 2008-05-01
EA013406B1 (ru) 2010-04-30
KR20080028316A (ko) 2008-03-31
NO20074889L (no) 2008-03-27
NZ561905A (en) 2009-01-31
CA2603274A1 (fr) 2008-03-26
ATE480544T1 (de) 2010-09-15
ES2351945T3 (es) 2011-02-14
WO2008037888A2 (fr) 2008-04-03
GEP20104877B (en) 2010-01-11
AR062950A1 (es) 2008-12-17
WO2008037888A3 (fr) 2008-06-12
FR2906249B1 (fr) 2008-12-19
DE602007009004D1 (de) 2010-10-21
UA96125C2 (ru) 2011-10-10
ZA200708215B (en) 2008-09-25
HRP20100605T1 (hr) 2010-12-31
MA29371B1 (fr) 2008-04-01
CA2603274C (fr) 2010-08-31

Similar Documents

Publication Publication Date Title
ZA200704957B (en) Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
SG151172A1 (en) 1,2,4,5-tetrahydro-3h-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them
AP3024A (en) New Diosmetin compounds, a process for their preparation and pharmaceutical compositions containing them
IL193340A0 (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
IL200128A0 (en) New tricyclic compounds, a process for their preparation and pharmaceutical compositions containing them
HK1155742A1 (en) Dihydroindolone compounds, a process for their preparation and pharmaceutical compositions containing them
HK1096386A1 (en) Indanyl-piperazine compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200603810B (en) Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them
IL205710A (en) History of Spiro [Pipyridine-Benzopyran] Pharmaceuticals Containing Them, Methods of Preparing and Using Their @
HK1096097A1 (en) Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them
HK1126190A1 (en) Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them
HK1093986A1 (en) Piperazine compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200704955B (en) Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
ZA201000025B (en) New naphthalene compounds,a process for their preparation and pharmaceutical compositions containing them
IL206885A0 (en) New chromene compounds, a process for their preparation and pharmaceutical compositions containing them
GB0612695D0 (en) Process for preparing a solid dosage form
ZA200704956B (en) Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200800833B (en) New 1H-indole-pyridinecarboxamide and 1H-indolepiperidinecarboxamide compounds, a process for their preparation and pharmaceutical compositions containing them
AP2009004891A0 (en) New azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them
ZA201000024B (en) New naphthalene compounds,a process for their preparation and pharmaceutical compositions containing them
HK1119163A1 (en) Tetracyclic compounds, a process for their preparation and pharmaceutical compositions containing them
AP2010005327A0 (en) New chromene compounds, a process for their preparation and pharmaceutical compositions containing them.
HUP0600918A3 (en) 3-benzenesulfonyl-quinoline derivatives, process for producing them, pharmaceutical compositions containing them and intermediates

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150924